The activity of pyrazolo[4,3-e][1,2,4]triazine and pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;71(6):1–23.
   Google Scholar
• Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJL, World Health Organization. Cancer incidence, mortality and survival by site for 14 regions of the world; 2001. Geneva. https://apps.who.int/iris/handle/10665/67775.
   Google Scholar
• Dai X, Cheng H, Bai Z, Li J. Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer. 2017;8(16):3131–3141.
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B, Senn H-J, Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24(9):2206–2223.
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4(11):891–899.
   PubMed Web of Science ®Google Scholar
• Heravi M, Zadsirjan V. Prescribed drugs containing nitrogen heterocycles: an overview. RSC Adv. 2020;10(72):44247–44311.
   PubMed Web of Science ®Google Scholar
• Kerru N, Gummidi L, Maddila S, Gangu KK, Jonnalagadda SB. A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules. 2020;25(8):1909.
   PubMed Web of Science ®Google Scholar
• Mojzych M, Bernat Z, Karczmarzyk Z, Matysiak J, Fruziński A. Synthesis, structural characterization, and biological activity of new pyrazolo[4,3-e][1,2,4]triazine acyclonucleosides. Molecules. 2020;25(1):221.
   PubMed Web of Science ®Google Scholar
• Mojzych M, Ceruso M, Bielawska A, Bielawski K, Fornal E, Supuran CT. New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors. Bioorg Med Chem. 2015;23(13):3674–3680.
   PubMed Web of Science ®Google Scholar
• Mojzych M, Dolashki A, Voelter W. Synthesis of pyrazolo[4,3-e][1,2,4]triazine sulfonamides, novel sildenafil analogs with tyrosinase inhibitory activity. Bioorg Med Chem. 2014;22(23):6616–6624.
   PubMed Web of Science ®Google Scholar
• Bernat Z, Szymanowska A, Kciuk M, Kotwica-Mojzych K, Mojzych M. Review of the synthesis and anticancer properties of pyrazolo[4,3-e][1,2,4]triazine derivatives. Molecules. 2020;25(17):3948.
   PubMed Web of Science ®Google Scholar
• Gornowicz A, Szymanowska A, Mojzych M, Bielawski K, Bielawska A. The effect of novel 7-methyl-5-phenyl-pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine sulfonamide derivatives on apoptosis and autophagy in DLD-1 and HT-29 colon cancer cells. Int J Mol Sci. 2020;21(15):5221.
   PubMed Web of Science ®Google Scholar
• Gornowicz A, Szymanowska A, Mojzych M, Czarnomysy R, Bielawski K, Bielawska A. The anticancer action of a novel 1,2,4-triazine sulfonamide derivative in colon cancer cells. Molecules. 2021;26(7):2045.
   PubMed Web of Science ®Google Scholar
• Hermanowicz JM, Szymanowska A, Sieklucka B, Czarnomysy R, Pawlak K, Bielawska A, Bielawski K, Kalafut J, Przybyszewska A, Surazynski A, et al. Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer. J Enzyme Inhib Med Chem. 2021;36(1):535–548.
   PubMed Web of Science ®Google Scholar
• Cascioferro S, Parrino B, Spanò V, Carbone A, Montalbano A, Barraja P, Diana P, Cirrincione G. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds. Eur J Med Chem. 2017;142:328–375.
   PubMed Web of Science ®Google Scholar
• Szymanowska A, Gornowicz A, Bielawska A, Bielawski K. [1,2,4]triazines – as potential drugs in cancer chemotherapy. Postepy Hig Med Dosw. 2021;75:64–84.
   Web of Science ®Google Scholar
• Rai GS, Maru JJ. Synthetic strategies for pyrrolo[2,1-f][1,2,4]triazine: the parent moiety of antiviral drug remdesivir. Chem Heterocycl Compd. 2020;56(12):1517–1522.
   PubMed Web of Science ®Google Scholar
• Fortin S, Bérubé G. Advances in the development of hybrid anticancer drugs. Expert Opin Drug Discov. 2013;8(8):1029–1047.
   PubMed Web of Science ®Google Scholar
• Nepali K, Sharma S, Sharma M, Bedi PMS, Dhar KL. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur J Med Chem. 2014;77:422–487.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Casini A, Scozzafava A. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents. Med Res Rev. 2003;23(5):535–558.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Owa T, Mastrolorenzo A, Supuran CT. Anticancer and antiviral sulfonamides. Curr Med Chem. 2003;10(11):925–953.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev. 2003;23(2):146–189.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem. 2007;15(13):4336–4350.
   PubMed Web of Science ®Google Scholar
• Mojzych M, Rykowski A. Synthesis of functionalized 1H-pyrazolo[4,3-e][1,2,4]triazines and their fused derivatives via IPSO-substitution of methylsulfonyl group with O-, N-, S- and C-nucleophiles. ChemInform. 2004;35(50):35.
   Google Scholar
• Czarnomysy R, Radomska D, Muszyńska A, Hermanowicz JM, Prokop I, Bielawska A, Bielawski K. Evaluation of the anticancer activities of novel transition metal complexes with berenil and nitroimidazole. Molecules. 2020;25(12):2860.
   PubMed Web of Science ®Google Scholar
• Radomska D, Czarnomysy R, Szymanowska A, Radomski D, Domínguez-Álvarez E, Bielawska A, Bielawski K. Novel selenoesters as a potential tool in triple-negative breast cancer treatment. Cancers. 2022;14(17):4304.
   PubMed Web of Science ®Google Scholar
• Czarnomysy R, Muszyńska A, Rok J, Rzepka Z, Bielawski K. Mechanism of anticancer action of novel imidazole platinum(II) complex conjugated with G2 PAMAM-OH dendrimer in breast cancer cells. Int J Mol Sci. 2021;22(11):5581.
   PubMed Web of Science ®Google Scholar
• Shirato K, Imaizumi K, Abe A, Tomoda A. Phenoxazine derivatives induce caspase-independent cell death in human glioblastoma cell lines, A-172 and U-251 MG. Oncol Rep. 2007;17(1):201–208.
   PubMed Web of Science ®Google Scholar
• Hseu Y-C, Lin R-W, Shen Y-C, Lin K-Y, Liao J-W, Thiyagarajan V, Yang H-L. Flavokawain B and doxorubicin work synergistically to impede the propagation of gastric cancer cells via ROS-mediated apoptosis and autophagy pathways. Cancers. 2020;12(9):2475.
   PubMed Web of Science ®Google Scholar
• Haisler WL, Timm DM, Gage JA, Tseng H, Killian TC, Souza GR. Three-dimensional cell culturing by magnetic levitation. Nat Protoc. 2013;8(10):1940–1949.
   PubMed Web of Science ®Google Scholar
• Czarnomysy R, Bielawski K, Muszynska A, Bielawska A, Gornowicz A. Biological evaluation of dimethylpyridine–platinum complexes with potent antiproliferative activity. J Enzyme Inhib Med Chem. 2016;31(Suppl. 3):150–165.
   PubMedGoogle Scholar
• Gupta SC, Hevia D, Patchva S, Park B, Koh W, Aggarwal BB. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal. 2012;16(11):1295–1322.
   PubMed Web of Science ®Google Scholar
• Kumar Rajendran N, George BP, Chandran R, Tynga IM, Houreld N, Abrahamse H. The influence of light on reactive oxygen species and NF-κB in disease progression. Antioxidants. 2019;8(12):640.
   Web of Science ®Google Scholar
• Takai A, Marusawa H, Minaki Y, Watanabe T, Nakase H, Kinoshita K, Tsujimoto G, Chiba T. Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation. Oncogene. 2012;31(13):1733–1742.
   PubMed Web of Science ®Google Scholar
• Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death – a new approach to cancer therapy. J Clin Invest. 2005;115(10):2625–2632.
   PubMed Web of Science ®Google Scholar
• De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R, Franzoso G. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature. 2001;414(6861):308–313.
   PubMed Web of Science ®Google Scholar
• Huang M, Xin W. Matrine inhibiting pancreatic cells epithelial–mesenchymal transition and invasion through ROS/NF-κB/MMPs pathway. Life Sci. 2018;192:55–61.
   PubMed Web of Science ®Google Scholar
• George BP, Abrahamse H. Increased oxidative stress induced by rubus bioactive compounds induce apoptotic cell death in human breast cancer cells. Oxid Med Cell Longev. 2019;2019:6797921.
   PubMed Web of Science ®Google Scholar
• Westphal D, Kluck RM, Dewson G. Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis. Cell Death Differ. 2014;21(2):196–205.
   PubMed Web of Science ®Google Scholar
• Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9(6):1799–1805.
   PubMed Web of Science ®Google Scholar
• Wang Z, Sun Y. Targeting p53 for novel anticancer therapy. Transl Oncol. 2010;3(1):1–12.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, Synnott NC, Crown J. Mutant p53 in breast cancer: potential as a therapeutic target and biomarker. Breast Cancer Res Treat. 2018;170(2):213–219.
   PubMed Web of Science ®Google Scholar
• Jänicke RU. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat. 2009;117(1):219–221.
   PubMed Web of Science ®Google Scholar
• van der Walt NB, Zakeri Z, Cronjé MJ. The induction of apoptosis in A375 malignant melanoma cells by Sutherlandia frutescens. Evid Based Complement Alternat Med. 2016;2016:4921067.
   PubMed Web of Science ®Google Scholar
• Brech A, Ahlquist T, Lothe RA, Stenmark H. Autophagy in tumour suppression and promotion. Mol Oncol. 2009;3(4):366–375.
   PubMed Web of Science ®Google Scholar
• Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer. 2005;103(8):1551–1560.
   PubMed Web of Science ®Google Scholar
• Chen N, Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim Biophys Acta. 2009;1793(9):1516–1523.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer. 2001;94(2):153–156.
   PubMed Web of Science ®Google Scholar
• Omar A. Anticancer activities of some fused heterocyclic moieties containing nitrogen and/or sulfur heteroatoms. Al-Azhar J Pharm Sci. 2020;62(2):39–54.
   Google Scholar
• Bernat Z, Mieszkowska A, Mazerska Z, Matysiak J, Karczmarzyk Z, Kotwica-Mojzych K, Mojzych M. Chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides—their biological activity, lipophilicity, protein affinity, and metabolic transformations. Appl Sci. 2021;11(6):2660.
   Google Scholar
• Hermanowicz JM, Pawlak K, Sieklucka B, Czarnomysy R, Kwiatkowska I, Kazberuk A, Surazynski A, Mojzych M, Pawlak D. MM-129 as a novel inhibitor targeting PI3K/AKT/mTOR and PD-L1 in colorectal cancer. Cancers. 2021;13(13):3203.
   PubMed Web of Science ®Google Scholar
• Szymanowska A, Gornowicz A, Bielawska A, Bielawski K. [1,2,4]triazines – as potential drugs in cancer chemotherapy. Postępy Higieny i Medycyny Doświadczalnej. 2021;75(1):64–84.
   Google Scholar
• Dhillon S. Avapritinib: first approval. Drugs. 2020;80(4):433–439.
   PubMed Web of Science ®Google Scholar
• von Mehren M, Heinrich MC, Shi H, Iannazzo S, Mankoski R, Dimitrijević S, Hoehn G, Chiroli S, George S. Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data. BMC Cancer. 2021;21(1):291.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Avapritinib for the treatment of CKIT or PDGFRA mutation-positive locally advanced or metastatic malignant solid tumors; 2021 [Internet] [accessed 2021 Dec 12]. https://clinicaltrials.gov/ct2/show/NCT04771520?term=triazine&draw=2&rank=5
   Google Scholar
• Mojzych M, Bielawska A, Bielawski K, Ceruso M, Supuran CT. Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity. Bioorg Med Chem. 2014;22(9):2643–2647.
   PubMed Web of Science ®Google Scholar
• Gucký T, Řezníčková E, Džubák P, Hajdúch M, Kryštof V. Synthesis and anticancer activity of some 1,5-diaryl-3-(3,4,5-trihydroxyphenyl)-1H-pyrazolo[4,3-e][1,2,4]triazines. Monatsh Chem. 2010;141(6):709–714.
   Web of Science ®Google Scholar
• Mojzych M. Cytotoxic activity of some pyrazolo[4,3-e][1,2,4]triazines against human cancer cell lines. J Chem Soc Pak. 2011;33:123–128.
   Web of Science ®Google Scholar
• Nguyen LA, He H, Pham-Huy C. Chiral drugs: an overview. Int J Biomed Sci. 2006;2(2):85–100.
   PubMedGoogle Scholar
• Wainer IW. Stereoisomers in clinical oncology: why it is important to know what the right and left hands are doing. Ann Oncol. 1993;4(Suppl. 2):7–13.
   PubMedGoogle Scholar
• Pfeffer CM, Singh ATK. Apoptosis: a target for anticancer therapy. Int J Mol Sci. 2018;19(2):448.
   PubMed Web of Science ®Google Scholar
• Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, Liang X. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37(1):266.
   PubMedGoogle Scholar
• Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863(12):2977–2992.
   PubMed Web of Science ®Google Scholar
• Huang S-M, Hsu P-C, Chen M-Y, Li W-S, More SV, Lu K-T, Wang Y-C. The novel indole compound SK228 induces apoptosis and FAK/paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse. Int J Cancer. 2012;131(3):722–732.
   PubMed Web of Science ®Google Scholar
• Wang Y, Luo YH, Piao XJ. Novel 1,4‑naphthoquinone derivatives induce reactive oxygen species‑mediated apoptosis in liver cancer cells. Mol Med Rep. 2019;19(3):1654–1664.
   PubMed Web of Science ®Google Scholar
• Mohan S, Abdelwahab SI, Kamalidehghan B, Syam S, May KS, Harmal NSM, Shafifiyaz N, Hadi AHA, Hashim NM, Rahmani M, et al. Involvement of NF-κB and Bcl2/Bax signaling pathways in the apoptosis of MCF7 cells induced by a xanthone compound pyranocycloartobiloxanthone A. Phytomedicine. 2012;19(11):1007–1015.
   PubMed Web of Science ®Google Scholar
• Zaki I, Abdelhameid MK, El-Deen IM, Abdel Wahab AHA, Ashmawy AM, Mohamed KO. Design, synthesis and screening of 1,2,4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line. Eur J Med Chem. 2018;156:563–579.
   PubMed Web of Science ®Google Scholar
• Boice A, Bouchier-Hayes L. Targeting apoptotic caspases in cancer. Biochim Biophys Acta Mol Cell Res. 2020;1867(6):118688.
   PubMed Web of Science ®Google Scholar
• Leber B, Lin J, Andrews DW. Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis. 2007;12(5):897–911.
   PubMed Web of Science ®Google Scholar
• Van Waes C, Chang AA, Lebowitz PF, Druzgal CH, Chen Z, Elsayed YA, Sunwoo JB, Rudy SF, Morris JC, Mitchell JB, et al. Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;63(5):1400–1412.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486–541.
   PubMed Web of Science ®Google Scholar
• Buzun K, Gornowicz A, Lesyk R, Bielawski K, Bielawska A. Autophagy modulators in cancer therapy. Int J Mol Sci. 2021;22(11):5804.
   PubMed Web of Science ®Google Scholar
• Deng S, Shanmugam MK, Kumar AP, Yap CT, Sethi G, Bishayee A. Targeting autophagy using natural compounds for cancer prevention and therapy. Cancer. 2019;125(8):1228–1246.
   PubMed Web of Science ®Google Scholar
• Ciołczyk-Wierzbicka D, Zarzycka M, Gil D, Laidler P. mTOR inhibitor Everolimus-induced apoptosis in melanoma cells. J Cell Commun Signal. 2019;13(3):357–368.
   PubMed Web of Science ®Google Scholar
• Doherty J, Baehrecke EH. Life, death and autophagy. Nat Cell Biol. 2018;20(10):1110–1117.
   PubMed Web of Science ®Google Scholar
• Liu W, Li S, Qu Z, Luo Y, Chen R, Wei S, Yang X, Wang Q. Betulinic acid induces autophagy-mediated apoptosis through suppression of the PI3K/AKT/mTOR signaling pathway and inhibits hepatocellular carcinoma. Am J Transl Res. 2019;11(11):6952–6964.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang W, Yu W, Xie Y, Zhang X, Zhang Y, Ma X. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing. Biotechnol Prog. 2005;21(4):1289–1296.
   PubMed Web of Science ®Google Scholar
• Madsen SJ, Sun C-H, Tromberg BJ, Cristini V, De Magalhães N, Hirschberg H. Multicell tumor spheroids in photodynamic therapy. Lasers Surg Med. 2006;38(5):555–564.
   PubMed Web of Science ®Google Scholar
• Anada T, Masuda T, Honda Y, Fukuda J, Arai F, Fukuda T, Suzuki O. Three-dimensional cell culture device utilizing thin membrane deformation by decompression. Sens Actuators B. 2010;147(1):376–379.
   Web of Science ®Google Scholar
• Santini MT, Rainaldi G, Indovina PL. Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol. 2000;36(2–3):75–87.
   PubMed Web of Science ®Google Scholar
• Kim JB. Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol. 2005;15(5):365–377.
   PubMed Web of Science ®Google Scholar